Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...

Danny Sprinkle watches the Huskies face Illinois. / Skylar Lin Visuals Danny Sprinkle takes his University of Washington basketball team on the road to face the No. 15 Oregon Ducks in a late-night ...

Given most of these remotes bear some resemblance to one another, you may have even wondered if they were interchangeable. After all, it makes sense that Amazon would make it easy on its customers ...

Sprinkle spoke post-game after Washington's 91-75 loss at Michigan Sunday and praised his teams fight, their grit, and their ability to improve a lot after losing by 34 Thursday night to Michigan ...

Puppy Bowl XXI will feature 142 rescue puppies from 80 shelters across 40 states and two countries. Team Fluff and Team Ruff will compete for the Walmart “Lombarky” trophy. Viewers can vote ...

Interchangeable knitting needles have revolutionized knitting for everyone, from beginners to experts. These versatile needles enable you to adjust the needle ends and cables to create any size or ...

"Our wedding was so surreal and the best day of our lives," the groom tells PEOPLE Lorin Kelly | @lorinkelly Jordan Sprinkle is married! The professional baseball player, 23, tied the knot with ...

Ingrezza Sprinkle (valbenazine) offers an alternative for those who have trouble swallowing pills or prefer a different method of taking medication. The U.S. Food and Drug Administration (FDA) has ...

Valbenazine tosylate (NBI-98854, Ingrezza, Dysval, Gisbal, Ingrezza Sprinkle) is an anti-dyskinesia agent. It is formulated as hard gelatin capsules for oral route of administration. It is indicated ...

The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for ...

On Thursday, RBC's latest "Game Changers" report highlighted potential innovations and disruptions that could significantly impact the biotech sector. The report, led by Brian Abrahams, the firm's ...